In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.

Slides:



Advertisements
Similar presentations
Inpatient Hyperglycemia Management
Advertisements

Surgery In Diabetes Mellitus (DM)
Block 9 Board Review Endocrine/Rheum 14Feb14 Chauncey D. Tarrant, M.D. Chief of Residents
Managing T2DM during Ramadan Dr. Asrar Said Hashem Specialist in Internal Medicine (Al-Amiri Hospital) Fellow of KIMS Endocrine, Diabetes and Metabolism.
University of Minnesota – School of Nursing Spring Research Day Glycemic Control of Critically Ill Patients Lynn Jensen, RN; Jessica Swearingen, BCPS,
Introducing The SHINE Trial (Stroke Hyperglycemia Insulin Network Effort) An Overview for Clinical Nurses NIH-NINDS U01 NSO69498.
Canadian Diabetes Association Clinical Practice Guidelines Acute Coronary Syndromes and Diabetes Chapter 26 Jean-Claude Tardif, Phillipe L. L’Allier, David.
Transition of Care in patients with diabetes Medha Munshi, MD Joslin Diabetes Center Beth Israel Deaconess Medical Center Harvard Medical School.
MMI Task Force on Diabetes House Staff Curriculum.
Stepwise approach to inpatient diabetes management Erin Keely.
Diabetes (abridged!). Who needs screening for DM? Age >45 Obese – BMI >25 1 st degree relative with DM Racial groups: –African American –Hispanic American.
Canadian Diabetes Association Clinical Practice Guidelines In-Hospital Management of Diabetes Chapter 16 Robyn Houlden, Sara Capes, Maureen Clement, David.
HOSPITAL BASED MANAGEMENT OF DIABETES MELLITUS
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
Management of Diabetes Mellitus in the Hospital
INPATIENT DIABETES GUIDE Ananda Nimalasuriya M.D..
Correction Insulin for Inpatient Hyperglycemia Estelle Lin June 2012.
Insulin therapy.
INSULIN THERAPHY Dilum Weliwita B. Sc Nursing ( UK )
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Protocol Cases and Q&A Karen C. Johnston, MD, MSc Administrative PI.
Perioperative Diabetes Management Dr. Ken Locke March 2007.
LONG TERM BENEFITS OF ORAL AGENTS
DIABETES MELLLITUS Strategies for Achieving Control in an Office Setting.
Kathryn A. Hanavan ANP-BC; BC-ADM Harold Schnitzer Diabetes Health Center September 12,
Management of Inpatient Blood Glucose at Temple Housestaff Orientation 2014.
Clinical Update in Type 2 Diabetes A Case Discussion Dr. Yancey R. Holmes, MD, FACE Ohio Valley Endocrinology.
Module 3 Initial Recognition, Triaging, and Management of Hyperglycemia Diabetes Special Interest Group Georgia Hospital Association.
Titrating Insulin to Glycemic Target Judy Bowen, MD CIM Rotation September, 2006.
Basal and Meal Time Insulin Case Study
MANAGEMENT OF THE HOSPITALIZED TYPE I DIABETIC PATIENT Riverside Methodist Hospital January 23, 2014 Rundsarah Tahboub, MD.
Inpatient Glycemic Management
Diabetes Update Division of Endocrinology Department of Medicine Wayne State University Medical School Detroit, Michigan Part 3 of 3.
The Basics of Insulin Pump Therapy Diabetes Care Center Patty Lord, RN,BSN, CDE Joyce Jones, RN,BSN,CDE Revised 8/2012.
DIABETES MELLITUS THOMAS MILLIGAN, DO OSU-COM FAMILY MEDICINE.
Basal Bolus: The Strategy for Managing All Diabetes Fall, 2003 Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
K. Ann Caudell, PhD, ACNP - BC. * Identify patients with out-of-range CBGs * Assist in maintaining CBGs between 80 mg/dL & 180 mg/dL during hospitalization.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 4.
INSULIN PUMPS Shelby Polk DNP, FNP-BC, CDE. 2 MANAGEMENT OF DIABETES IN SCHOOLS Exercise Legal Rights Health & Learning Nutrition Insulin Administration.
Insulins Roland Halil, BScPharm, ACPR, PharmD Clinical Pharmacist, Bruyere Academic Family Health Team Assistant Professor, Dept of Family Medicine, U.
1 Module 5 Pharmacologic Management of Hospital Hyperglycemia: Insulin Management Part 2 Diabetes Special Interest Group Georgia Hospital Association.
Adult SQ Insulin Advisor Be on the look-out for VUMC’s new subcutaneous adult insulin advisor Orderable in WIZ/HEO. Physician Driven, unlike the Insulin.
Achieving Glycemic Control in the Hospital Setting
ADDITIONAL SLIDES FOR ASSIST WITH COMPREHENSION OF LAB CONTENT-MODULE FIVE-DM DENISE TURNER, MS-N.ED, RN, CCRN.
Journal Club 9/15/11 Sanaz Sakiani, MD 1 st Year Endocrine Fellow Combining Basal Insulin Analogs with Glucagon-Like Peptide-1 Mimetics.
DIABETIC KETOACIDOSIS Emergency pediatric – PICU division H. Adam Malik Hospital – Medical School University of Sumatera Utara 1.
Medical Management of Diabetes During Ramadan Jennifer Hamilton, MD August, 2007 CE Rajab, 1428 AH.
Special Situations In The Management Of In-Patient Hyperglycemia
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocol Cases.
Strategies to Reduce Hypoglycemia Presented by: Hennie Garza, M.S., R.Ph., C.D.E, Director of Pharmacy Utilization and Outcomes Senior Care Centers
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
New Subcutaneous Insulin Protocol for Type 2 Diabetics
Insulins Roland Halil, BScPharm, ACPR, PharmD
Insulin Initiation and Titration
Inpatient Glycemic Management
Pharmacy Protocol for Insulin Dosing in the Hospitalized Patient
EndoTool IV Physician User Guide Content Expert:
Management of diabetes mellitus in hospitalized patients
Insulins Roland Halil, BScPharm, ACPR, PharmD
Insulins Roland Halil, BScPharm, ACPR, PharmD
Ramadan Fasting and Diabetes Mellitus
T1DM: Insulin Initiation
Approach to starting and adjusting insulin in type 2 diabetes.
Managing Hypoglycemia & Hyperglycemia
A: Subcutaneous insulin therapy may be selected as continuation of ambulatory therapy, as new therapy, or as a transition plan from intravenous infusion.
INSULINS Dr.R.Sajjad december INSULINS Dr.R.Sajjad december 2018.
Insulin Delivery Systems Atlanta Diabetes Associates
Inpatient Insulin Management on the Wards
Insulin in Type 2 Diabetes
Celia Levesque MSN, RN, CNS-BC, NP-C, CDE, BC-ADM
NEW INSULIN ORDER SETS (NON-ICU AREAS)
Presentation transcript:

In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center

Case 1: Floor Patient 40M diabetic is admitted to the regular floor with protracted vomiting and is diagnosed with acute pyelonephritis. He takes metformin at home but does not check his glucose. Weight is 100 kg. HbA1C is 10. IV dextrose is started. In-patient glycemic values range between mg/dL despite regular insulin sliding scale Q6. What is the best regimen while in the hospital? 40M diabetic is admitted to the regular floor with protracted vomiting and is diagnosed with acute pyelonephritis. He takes metformin at home but does not check his glucose. Weight is 100 kg. HbA1C is 10. IV dextrose is started. In-patient glycemic values range between mg/dL despite regular insulin sliding scale Q6. What is the best regimen while in the hospital? A. Continue metformin + TZD A. Continue metformin + TZD B. D/C oral agents and start Lantus 5 U PM B. D/C oral agents and start Lantus 5 U PM C. D/C oral agents and start Lantus 30 units PM + regular insulin SS C. D/C oral agents and start Lantus 30 units PM + regular insulin SS D. D/C oral agents and start 70/30 insulin 20 units BID D. D/C oral agents and start 70/30 insulin 20 units BID

Answer Pre-prandial goal: mg/dL (floor) Pre-prandial goal: mg/dL (floor) : close to 110 mg/dL (ICU) : close to 110 mg/dL (ICU) Basal insulin (NPH or Lantus) Basal insulin (NPH or Lantus) : start at U/kg/day : adjust 10-20% of total dose Q1-2 days Correction insulin by SS Q6 hours Correction insulin by SS Q6 hours Avoid hypoglycemia! Avoid hypoglycemia! (Beware of “brittle” diabetics.)

Harmful Hyperglycemia Enhanced tissue injury, poor wound healing Enhanced tissue injury, poor wound healing Increased inflammation, oxidative stress Increased inflammation, oxidative stress Lowered immune resistance Lowered immune resistance Endothelial dysfunction Endothelial dysfunction Platelet aggregation Platelet aggregation Potentiation of myocardial and cerebral ischemia Potentiation of myocardial and cerebral ischemia

Important Factors Severity of illness Severity of illness Concurrent medications Concurrent medications Diet Diet History of DM, meds and control History of DM, meds and control

Types of Insulin ONSETPEAKDURATION RAPID-acting Humalog mins. 30 min-2.5 hrs. 3-5 hrs. SHORT-acting Regular (R) 30 min-1 hr. 2-5 hrs. 5-8 hrs. INTERMEDIATE-acting NPH (N) 1-2 hrs hrs hrs. LONG-acting Lantus hrs. None hrs. PRE-MIXED 70/30 30 mins. 2-4 hrs hrs. The Cleveland Clinic Health Information Center

Insulin Advantages Safe for any age Safe for any age Safe for heart, kidney, liver dysfunction Safe for heart, kidney, liver dysfunction Rapid onset and clearance Rapid onset and clearance Few drug interactions Few drug interactions

Case 1-B: Eating by mouth After 2 days, the patient feels better and starts eating. In the last 24 hours, his glucose values ranged between mg/dL and he received total correction regular insulin dose of 20 units. What is the best approach now? After 2 days, the patient feels better and starts eating. In the last 24 hours, his glucose values ranged between mg/dL and he received total correction regular insulin dose of 20 units. What is the best approach now? A. Do no changes A. Do no changes B. Retain current insulin therapy and resume metformin + TZDs B. Retain current insulin therapy and resume metformin + TZDs C. Increase Lantus to 32 U PM + regular insulin SS C. Increase Lantus to 32 U PM + regular insulin SS D. Increase Lantus to 36 U PM + 2 U regular insulin pre-meals D. Increase Lantus to 36 U PM + 2 U regular insulin pre-meals E. Increase Lantus to 36 U PM + regular insulin 5 U pre-meals + regular insulin SS E. Increase Lantus to 36 U PM + regular insulin 5 U pre-meals + regular insulin SS

Answer When a patient starts eating… May continue oral agents IF no contraindications or if glucose controlled May continue oral agents IF no contraindications or if glucose controlled GLUCOSE TOXICITY GLUCOSE TOXICITY Recommendation: Basal + Recommendation: Basal + Prandial ( U/kg/day) + Correction insulin Prandial ( U/kg/day) + Correction insulin

Case 2: Cont. Enteral Feeds 70M with stroke requires continuous G-tube feeding. Pre- hospital glucose regimen was sulfonylurea and metformin. Glucose values are consistently greater than 180 mg/dL with a caloric intake of 20 kcal/hr and his projected need is 70 kcal/hr. Weight is 70 kg. Which regimen is best? 70M with stroke requires continuous G-tube feeding. Pre- hospital glucose regimen was sulfonylurea and metformin. Glucose values are consistently greater than 180 mg/dL with a caloric intake of 20 kcal/hr and his projected need is 70 kcal/hr. Weight is 70 kg. Which regimen is best? A. Sulfonylurea + metformin at home doses A. Sulfonylurea + metformin at home doses B. Sulfonylurea + metformin + regular insulin SS B. Sulfonylurea + metformin + regular insulin SS C. NPH insulin 7 U AM and 7 U PM + Humalog SS Q4 C. NPH insulin 7 U AM and 7 U PM + Humalog SS Q4 D. NPH insulin 10 U AM and 5 U PM + Humalog SS Q4 D. NPH insulin 10 U AM and 5 U PM + Humalog SS Q4 E. 70/30 insulin 7 U Q12 + Humalog SS Q4 E. 70/30 insulin 7 U Q12 + Humalog SS Q4

Answer Insulin for continuous enteral feeding: Insulin for continuous enteral feeding: Basal + correction Basal + correction May divide insulin doses equally for AM and PM May divide insulin doses equally for AM and PM Adjustment for correction insulin example: Adjustment for correction insulin example: If total correction in last 24 hrs. is 10 units, may add 10 to Lantus or 5 for each NPH dose Increase insulin dose as feeding is increased Increase insulin dose as feeding is increased For TPN, may add regular insulin to bag For TPN, may add regular insulin to bag

Case 3: IV to SQ 65M with 20-year history of DM has glucose values of mg/dL while on an insulin drip at 2 U/hr in the ICU after CABG. He has been treated pre-operatively with NPH 40 U and regular insulin 10 U pre-meals with good control. Which regimen is best in transitioning to subQ insulin? 65M with 20-year history of DM has glucose values of mg/dL while on an insulin drip at 2 U/hr in the ICU after CABG. He has been treated pre-operatively with NPH 40 U and regular insulin 10 U pre-meals with good control. Which regimen is best in transitioning to subQ insulin? A. D/C drip and start regular insulin sliding scale (SS) A. D/C drip and start regular insulin sliding scale (SS) B. D/C drip and start NPH 5 U + regular insulin SS B. D/C drip and start NPH 5 U + regular insulin SS C. Continue drip for 2 hours and start NPH 20 U + regular insulin SS C. Continue drip for 2 hours and start NPH 20 U + regular insulin SS D. Continue drip for 2 hours and start Lantus 20 U + regular insulin SS D. Continue drip for 2 hours and start Lantus 20 U + regular insulin SS

Answer Use insulin type that has worked. Use insulin type that has worked. NPH acts faster than Lantus which has slower onset (maximal effect may not be seen for a few days). NPH acts faster than Lantus which has slower onset (maximal effect may not be seen for a few days). Starting basal insulin at half the pre-operative dose is generally safe. Starting basal insulin at half the pre-operative dose is generally safe. When the patient starts to eat, consider pre- prandial insulin. When the patient starts to eat, consider pre- prandial insulin.

Case 4: ICU patient A 70F is admitted to ICU for ARDS and hooked to a mechanical ventilator. She has no history of DM but glucose measurements in the first 6 hours range between mg/dL. What is the best treatment for hyperglycemia? A 70F is admitted to ICU for ARDS and hooked to a mechanical ventilator. She has no history of DM but glucose measurements in the first 6 hours range between mg/dL. What is the best treatment for hyperglycemia? A. Start insulin infusion. A. Start insulin infusion. B. Start basal insulin + regular insulin SS Q6 B. Start basal insulin + regular insulin SS Q6 C. Start basal insulin + pre-prandial insulin + regular insulin SS C. Start basal insulin + pre-prandial insulin + regular insulin SS D. Check glucose Q6 and correct with regular insulin SS only D. Check glucose Q6 and correct with regular insulin SS only E. Insert a nasogastric tube and pass metformin E. Insert a nasogastric tube and pass metformin

Answer In the ICU, optimal glycemic control may be achieved by continuous infusion with frequent hourly monitoring. In the ICU, optimal glycemic control may be achieved by continuous infusion with frequent hourly monitoring. Use the last 24 hour requirement to approximate total daily dose and divide into basal and pre- prandial accordingly. Use the last 24 hour requirement to approximate total daily dose and divide into basal and pre- prandial accordingly.

Take Home Points Know goals. Know goals. Get adequate BASAL insulin on board. Get adequate BASAL insulin on board. Sliding scale ALONE is usually insufficient. Sliding scale ALONE is usually insufficient. Monitor and adjust continuously. Monitor and adjust continuously.

Thank you